Pfizer on Tuesday announced an agreement allowing other companies to make its potential coronavirus antiviral pill in poorer countries and sell them royalty free. The move advances what Pfizer describes as its "comprehensive strategy to work toward equita
Pfizer on Tuesday announced an agreement allowing other companies to make its potential coronavirus antiviral pill in poorer countries and sell them royalty free. The move advances what Pfizer describes as its "comprehensive strategy to work toward equita